SELECT LANGUAGE BELOW

Giving up ultra-processed foods might double your weight-loss success, research indicates

Giving up ultra-processed foods might double your weight-loss success, research indicates

Study Highlights Impact of Eliminating Ultra-Processed Foods on Weight Loss A recent study indicates that avoiding a specific type of food can nearly double the results of weight loss efforts. Published on August 4 in the journal Nature Medicine, it reveals that overweight adults who stopped consuming ultra-processed foods (UPFs) lost almost twice the weight […]

Weight-loss medications associated with higher chances of eye problems and vision impairment

Weight-loss medications associated with higher chances of eye problems and vision impairment

Recent research indicates that some weight loss medications may be linked to a heightened risk of serious eye conditions, including potential vision loss. Two studies featured in Jama examined the effects of semaglutide and tilzepatide—common drugs like Ozempic, Wegovy, Munjaro, and Zepbound—on the eye health of Americans diagnosed with Type 2 diabetes over a two-year […]

Diabetes and weight-loss medications might also help with arthritis symptoms.

Diabetes and weight-loss medications might also help with arthritis symptoms.

The Benefits of GLP-1 Drugs Extend Beyond Diabetes and Weight Loss GLP-1 drugs, known for mimicking a hormone that regulates blood sugar, might have effects beyond managing diabetes and aiding in weight loss. Experts suggest that medications like semaglutide (Ozempic, Wegovy) and tilzepatide (Munjaro, Zepbound) could offer relief for those suffering from rheumatoid arthritis (RA). […]

The FDA needs to take action against hazardous counterfeit weight-loss medications.

The FDA needs to take action against hazardous counterfeit weight-loss medications.

Hope in the Fight Against Obesity For the first time, there’s a glimmer of hope in tackling obesity. Recent data from the National Center for Health Statistics at the CDC indicates that adult obesity rates in the US might finally stabilize after years of annual increases since at least 2011. Obesity, long understood to be […]

Patients with obesity and additional health issues are the best candidates for weight-loss medications.

Patients with obesity and additional health issues are the best candidates for weight-loss medications.

Weight loss medications are gaining traction, and it’s estimated that the global market for these therapies could hit $150 billion by 2035. Drugs like GLP-1 agonists—semaglutide-based options such as Ozempic, Wegovy, Mounjaro, and Zepbound—are primarily designed to treat type 2 diabetes and manage obesity. Interestingly, recent research suggests additional benefits that doctors are beginning to […]

Men share surprising changes to their genitals after using a weight-loss injection.

Men share surprising changes to their genitals after using a weight-loss injection.

Ozempic Users Report Unexpected Changes Interestingly, some users are noting surprising effects from this weight loss medication. One male user of Ozempic has claimed his penis has grown since starting the injections. In a conversation on Reddit, he mentioned, “I recently measured myself and found I gained about an inch.” He went on to suggest […]

Advancements in cancer research and Biden’s health diagnosis, along with benefits of weight-loss medications.

Top 3 Health Updates – Painkillers Linked to Longer Lives for Brain Cancer Patients – Biden’s Prostate Cancer: Understanding His Prognosis – Surprising Benefits of Weight Loss Medications This week, top stories in health centered around significant findings in brain cancer research, insights into President Biden’s health situation, and unexpected advantages of weight loss pills. […]

Research uncovers another health benefit of weight-loss drugs

Weight loss drugs known as glucagon-like peptide-1 (GLP-1) agonists, which have become quite popular for treating type 2 diabetes and obesity, show promising potential to also reduce alcohol consumption. An international research team from Ireland and Saudi Arabia studied 262 obese adults who began treatment with either liraglutide or semaglutide. For those who regularly drank, […]